New research presented at this year’s European Congress on Obesity (held online, 10-13 May) shows that the obesity drug semaglutide reduces appetite, food cravings and energy […]
An early study of a new experimental drug to treat obesity known as cagrilintide shows that, when combined with semaglutide 2.4 mg, the combination leads to […]
Authorities in Brazil’s most populous state on Wednesday said they have mobilized to try to convince the Chinese government to authorize the export of raw material […]